|
|
|
Abstract Objective To explore the effects of enteral combined parenteral nutrition treatment on the nutritional status, quality of life, chemotherapy toxicity and nosocomial infection for patients with advanced gastrointestinal cancer after two chemotherapy cycles. Methods Totally 100 patients were randomly divided into the treatment group and the control group. The treatment group (n=50) was treated with combined parenteral with enteral nutritional support and chemotherapy, the control group (n=50) was
provided with normal diet and chemotherapy. The nutritional status, toxicity reaction, quality of life, and nosocomial infection rate of the two groups were assessed and evaluated before and after each cycle of chemotherapy. Results There were no significant
differences of the nutritional status, quality of life and nosocomial infection rate between two groups before chemotherapy and after
the first cycle of chemotherapy. After two cycles of chemotherapy, the body mass index (19.59±4.05 vs 18.91±3.36, P<0.05) and
hemoglobin (109.5±7.55g/L vs 103.10±4.63g/L, P<0.05) were significantly higher than that in first cycle of chemotherapy. The
incidence of myelosuppression was significantly lower than that in control group (38.0% vs 70.0%, P<0.05). There were significant difference between nausea and vomiting in treatment group and the control group (22.0% vs 52.0%, P<0.05). The incidences of nosocomial infection in the treatment group were lower than in the control group (4.0% vs 26.0%, P<0.05). Conclusions Combined parenteral with enteral nutritional therapy after two chemotherapy cycles can not only ameliorate the nutritional status and quality of life of patients with advanced gastrointestinal cancer, but also alleviate the chemotherapy-induced adverse reaction, and prevent nosocomial infection.
|
|
|
|
|
|
| Cite this article: |
|
1 LI Fan,2 LI Jing,1 TIAN Cai-qin. Enteral and parenteral nutrition on efficacy and toxicity of chemotherapy for patients with gastrointestinal cancer[J]. Electronic Journal of Metabolism and Nutrition of, 2018, 5(1): 43-47.
|
|
|
|
| URL: |
| http://www.ejmnc.org/EN/ OR http://www.ejmnc.org/EN/Y2018/V5/I1/43 |
| [1] |
1FAN Yue-ping， 2ZHANG Tian， 2QU Qian-nuo， 3SHI Han-ping. Interpretation of expert consensus for nutritional therapy pathway of malignant tumor in China—peripheral venous catheterization[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 301-304. |
| [2] |
1YAO Ke-qing， 1WANG Su， 1CHEN Shuang， 1SUN Yan-teng， 1LIU Qing-yang， 1CHEN Tao，1LIU Xue-hui， 2CONG Ming-hua. Application of individualized nutrition diagnosis and intervention in patients with advanced cancer[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 305-309. |
| [3] |
1LIU Yong-bo，2，3DENG Li， 1GUO Yi-hui，1LI Yan-ping. Atg13 gene overexpression induces chemotherapy resistance in triple-negative breast cancer cells[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 310-315. |
| [4] |
1XUE Tao， 1WANG Wei-hong， 2MA Hui，1ZHANG Na，1ZHANG Sheng-Jun， 1DU Xin-ying . Application of perioperative nutritional support in patients with meningioma[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 326-331. |
| [5] |
1*LUO Min， 2*WU Xiao-jun， 2ZHANG Xin， 3DONG Guang， 4XIONG Li-long， 4WANG Peng-cheng， 1GAO Kui， 1YU Ping， 1HE Mei， 5DU Chi， 5JIANG Ou， 6SHI Han-ping . ABD bioactives alleviates chemotherapy-induced myelosuppression[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 346-350. |
| [6] |
1CHEN Hai-tao， 2LU Yi， 3XU Chao， 4GUO Yong， 3，5YAO Qing-hua. Exploration of a new mode of whole-process management of nutrition of gastrointestinal malignancy in Chinese and Western medicine[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 370-375. |
|
|
|
